Impact of Neoadjuvant Therapy on PD-L1 Expression in Triple-Negative Breast Cancer and Correlation with Clinicopathological Factors
In conclusion, PD-L1 expression in TNBC shows significant discordance post-treatment, highlighting the need for routine testing and further research on predictive biomarkers.
Authors
- Mina Pencheva (ORCID: https://orcid.org/0000-0002-0411-2291)
- Desislava Tashkova (ORCID: https://orcid.org/0000-0002-1158-1379)
- Pencho Georgiev (ORCID: https://orcid.org/0000-0001-5677-6754)
- Elena Daskalova (ORCID: https://orcid.org/0000-0002-6661-0747)
- Nevena Ilieva (ORCID: https://orcid.org/0009-0001-3614-3332)
- Sylvia Genova
- Hristo Hadzhiev
Institutions
- Medical University Plovdiv (BG)
Publication Details
- Journal
- Diagnostics
- Published
- 2024-11-27
- DOI
- https://doi.org/10.3390/diagnostics14232672
- Citations
- 3
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.85